Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipilimumab with Paclitaxel/Carboplatin in Lung Cancer
NCT00527735Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2008
- Primary completion
- Oct 2009
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 2 trial of ipilimumab in non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), sponsored by Bristol Myers Squibb. Started Feb 2008; status: completed.
02
Drugs
ipilimumab
03
Conditions
non-small cell lung cancer (NSCLC)small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00527735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527735.